Jing Tan

12PUBLICATIONS
66CO-AUTHORS
Neural networksMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 30, 2026
Nuclear NAD+ promotes innate immune memory by inhibiting KDM5A-dependent histone demethylation.

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Jan 09, 2026
PRMT5 upregulates KCNMB4 expression via histone methylation to promote paclitaxel resistance in advanced nasopharyngeal carcinoma.

Lizhen Liu, Sailan Liu, Yali Wang

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Oct 16, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.

Shini Liu, Peng Deng, Zhaoliang Yu

Pageof 2

Frequent Collaborators

5 joint publications

Jing Han Hong

5 joint publications

Bin Tean Teh

5 joint publications

Jason Yongsheng Chan

4 joint publications

Peiyong Guan